The myeloid cell type I IFN system promotes antitumor immunity over pro-tumoral inflammation in cancer T-cell therapy.
Clinical & translational immunology
View this publicationClinical & translational immunology
View this publicationJournal of translational medicine
View this publicationCell reports
View this publicationJournal of the American Chemical Society
View this publicationJournal of neuroinflammation
View this publicationAllergology international : official journal of the Japanese Society of Allergology
View this publicationThe Journal of infectious diseases
View this publicationFrontiers in chemistry
View this publicationBlood
View this publicationExpert opinion on pharmacotherapy
View this publication